x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Radio Advisory

A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry"s most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we"re here to help. Our hosts and seasoned

business management

All Episodes

6:12

258: The ‘One Big, Beautiful Bill Act’: What’s...

Radio Advisory ·

2025/07/08

On July 4th, 2025, President Donald Trump signed the “One Big Beautiful Bill Act” into law. In this “minisode,” host Rachel (Rae) Woods unpacks the sweeping implications of the most significant healthcare legislation since the Affordable Care Act. From enhanced subsidies expiring to major cuts to Medicaid and ACA marketplace coverage on the horizon, Rae explores what this legislation means for providers, payers, and the broader healthcare ecosystem. Listen to this short policy update for strategic

en-us

46:12

257: Paul Markovich on new builds, breakups, and bold...

Radio Advisory ·

2025/07/01

In this special live episode from the 2025 Advisory Board Summit, host Rachel (Rae) Woods sits down with a leader well-versed in bold transformation: Paul Markovich. After more than a decade as President and CEO of Blue Shield of California, Paul now leads Ascendiun—a new nonprofit parent company that includes Blue Shield of California, its clinical services firm Altais, and the newly launched health services business, Stellarus. Together, they explore the mounting pressures facing health plans and

en-us

31:07

256: How you can prepare for the financial impacts of...

Radio Advisory ·

2025/06/24

Healthcare executives are closely watching legislative activity in Congress—anticipating shifts in government-funded insurance, new economic headwinds, and regulatory changes. And while change is certainly coming, what remains uncertain is how these forces will shape market dynamics and organizational finances. To help hospitals and health systems prepare, Advisory Board’s quantitative experts developed an impact estimator to size the financial impact of Congress’s ‘One Big Beautiful Bill’. This

en-us

39:50

255: Is healthcare really recession-proof?

Radio Advisory ·

2025/06/17

When experts warn that the economy could be headed for a recession, people working across different corners of the economy get nervous. People working in healthcare, maybe less so. That’s because of a longstanding idea that healthcare is impervious to recession. Okay, maybe that’s overstating it. Healthcare is less susceptible than other industries. But did this notion hold up during the pandemic? During the Great Recession? More importantly, will it hold up now? This week on Radio Advisory, host

en-us

29:31

254: Stop searching for the “perfect” AI product and...

Radio Advisory ·

2025/06/10

Artificial intelligence (AI) continues to generate excitement across healthcare, promising to reduce clinician burnout, fuel innovation, and ease financial pressures. But despite the hype, AI is far from a “plug-and-play” solution—and simply investing in AI won’t guarantee success. This week, host Rachel (Rae) Woods is joined by Advisory Board AI expert Ty Aderhold to explore what it really takes to see value from AI in healthcare. Together, they unpack: The current reality of AI’s return on

en-us

29:05

253: A new way to measure patient access

Radio Advisory ·

2025/06/03

Stay tuned to the end of the episode for a policy update on the bill containing Medicaid cuts that is making its way through Congress, and the recent MAHA Commission Report. If you were to ask any healthcare leader what the top challenges in our industry are, it’s a fair bet that “improving patient access to care” would be on the list. There have been so many investments made in the industry to improve access—especially since the Covid-19 pandemic. With this level of investment, we should be

en-us

41:08

252: Contain, extract, recover: Inside the Ardent...

Radio Advisory ·

2025/05/27

In this special live episode from the 2025 Advisory Board Summit, Ardent Health Services President & CEO Marty Bonick and Chief Digital and Transformation Officer Anika Gardenhire recount the harrowing story of a ransomware attack that brought their 30-hospital system to a standstill on Thanksgiving Day 2023. Cyberattacks on healthcare systems are becoming more frequent, more sophisticated, and more devastating. Just 60 days into her role, Anika led the charge to contain the breach, extract the

en-us

40:26

251: Former HHS leaders weigh in on navigating Trump...

Radio Advisory ·

2025/05/20

It has been over 100 days since President Donald Trump began his second term. During that time, Radio Advisory has received a steady stream of questions from leaders seeking guidance in an uncertain policy and business environment. With looming funding cuts, the restructure of HHS, the arrival of DOGE and MAHA, and more, leaders are grappling with what to focus on, how to respond, and how to engage productively with the federal government. To help answer these questions, Radio Advisory turned to

en-us

40:25

251: Former HHS leaders weigh in on navigating Trump...

Radio Advisory ·

2025/05/20

5/22 Update: The House early Thursday narrowly passed the One Big Beautiful Bill Act, a budget bill that includes a number of healthcare provisions that could have a significant impact on Medicaid, Medicare, and the Affordable Care Act. It has been over 100 days since President Donald Trump began his second term. During that time, Radio Advisory has received a steady stream of questions from leaders seeking guidance in an uncertain policy and business environment. With looming funding cuts, the

en-us

34:17

250: VBC success is possible. Here's how Advocate...

Radio Advisory ·

2025/05/13

Believe it or not, 60% of healthcare payments in the US are tied to value. But it’s still surprisingly hard to find examples of health systems that have been doing VBC at scale, successfully, over time. So that’s what Advisory Board researchers set out to do. And across 66 conversations with 44 systems, we found four systems with approaches worth emulating. This week, we’re unpacking the approach at one of those systems: Advocate Health. Host Abby Burns sits down with Don Calcagno, Chief Population

en-us

34:16

250: VBC success is possible. Here's how Advocate...

Radio Advisory ·

2025/05/13

Believe it or not, 60% of healthcare payments in the US are tied to value. But it’s still surprisingly hard to find examples of health systems that have been doing VBC at scale, successfully, over time. So that’s what Advisory Board researchers set out to do. And across 66 conversations with 44 systems, we found four systems with approaches worth emulating. This week, we’re unpacking the approach at one of those systems: Advocate Health. Host Abby Burns sits down with Don Calcagno, Chief Population

en-us

21:47

[Encore] The changing tide of Medicare Advantage

Radio Advisory ·

2025/05/06

(This episode originally aired on October 22, 2024.) For years, the best word to describe Medicare Advantage (MA) was “untouchable.” Hugely popular among seniors, profitable for health plans—the hybrid public-private payment model grew to the point that it now covers more seniors than traditional Medicare. But in the past few years, the tide has started to change. And if you’ve been paying attention in recent months, you’ll have seen headlines announcing that payers that are scaling back their MA

en-us

21:46

[Encore] The changing tide of Medicare Advantage

Radio Advisory ·

2025/05/06

(This episode originally aired on October 22, 2024.) For years, the best word to describe Medicare Advantage (MA) was “untouchable.” Hugely popular among seniors, profitable for health plans—the hybrid public-private payment model grew to the point that it now covers more seniors than traditional Medicare. But in the past few years, the tide has started to change. And if you’ve been paying attention in recent months, you’ll have seen headlines announcing that payers that are scaling back their MA

en-us

32:16

249: What is 340B, and why is it in the hot seat

Radio Advisory ·

2025/04/29

The federal drug purchasing program known as 340B was created in 1992 to help select provider organizations stretch scarce resources to care for patients. More than three decades later, health systems of all shapes and sizes have come to rely on 340B for their financial sustainability. But the program has come under criticism. And in recent years, it’s been under more scrutiny, with manufacturers, state governments, and federal regulators proposing changes to how it operates. In this episode, host

en-us

32:15

249: What is 340B, and why is it in the hot seat

Radio Advisory ·

2025/04/29

The federal drug purchasing program known as 340B was created in 1992 to help select provider organizations stretch scarce resources to care for patients. More than three decades later, health systems of all shapes and sizes have come to rely on 340B for their financial sustainability. But the program has come under criticism. And in recent years, it’s been under more scrutiny, with manufacturers, state governments, and federal regulators proposing changes to how it operates. In this episode, host

en-us

35:20

248: Drugs, surgeries, and shortages: the state of...

Radio Advisory ·

2025/04/22

In 2025, 6% of US adults are taking a GLP-1. But the popularity of weight-loss drugs isn’t the only thing changing the obesity care landscape. On Radio Advisory, we’ve talked about what comprehensive obesity care looks like, the reality of weight bias, and the strain high-cost drugs like GLP-1s are having on employers and plans. But we haven’t done an updated scan of the obesity care landscape, until now. To share the state of the Obesity market in 2025, host Rachel (Rae) Woods invites Advisory

en-us

35:19

248: Drugs, surgeries, and shortages: the state of...

Radio Advisory ·

2025/04/22

In 2025, 6% of US adults are taking a GLP-1. But the popularity of weight-loss drugs isn’t the only thing changing the obesity care landscape. On Radio Advisory, we’ve talked about what comprehensive obesity care looks like, the reality of weight bias, and the strain high-cost drugs like GLP-1s are having on employers and plans. But we haven’t done an updated scan of the obesity care landscape, until now. To share the state of the Obesity market in 2025, host Rachel (Rae) Woods invites Advisory

en-us

28:50

247: How hospitals and post-acute providers can...

Radio Advisory ·

2025/04/15

Let’s face it: Hospitals and post-acute providers can find themselves at odds. Post-acute is an area of the industry that is often misunderstood and sometimes villainized. But when post-acute care struggles, it directly impacts hospital operations. The industry needs a solution. It starts with understanding that the post-acute space is not a monolith. Because only by understanding how different facilities struggle—and how systems can support or partner with them—can we unlock their potential. That’s

en-us

28:49

247: How hospitals and post-acute providers can...

Radio Advisory ·

2025/04/15

Let’s face it: Hospitals and post-acute providers can find themselves at odds. Post-acute is an area of the industry that is often misunderstood and sometimes villainized. But when post-acute care struggles, it directly impacts hospital operations. The industry needs a solution. It starts with understanding that the post-acute space is not a monolith. Because only by understanding how different facilities struggle—and how systems can support or partner with them—can we unlock their potential. That’s

en-us

35:56

246: Plans have trust and cost problems. Here's how...

Radio Advisory ·

2025/04/08

Every stakeholder in healthcare is getting squeezed by mounting financial pressures, and health plans are no exception. Higher utilization and rising treatment costs are hitting plans hard. At the same time, plans are facing heightened public scrutiny. It may seem like the wrong time for plans to focus on cost management, but the combination of market and public pressures is exactly why it is so important for plans to get a handle on their clinical costs. If not, they risk passing those costs on to

en-us

316 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...